Summary
The reactivity of two monoclonal antibodies recognizing NCA-95 and NCA-55 (MAb 47 and MAb 192, respectively) with a polyclonal anti-NCA serum in myeloid leukemic cells isolated by density gradient centrifugation was compared using an immunofluorescence test (IF). It was observed that the blood myeloid cells in 78.8% of the patients with different types of myelocytic leukemias and all granulocytes of 15 normal donors showed similar expression of the NCA species studied. The leukocytes of the remaining patients did not synthesize the NCA-95 species regardless of the maturation stage of the cells studied. In two patients, synthesis of this NCA form was limited to the fractions containing myelocytes and metamyelocytes. We have found that all anti-NCA antibodies studied recognized different antigenic epitopes in a myeloid cell series. A relationship between the patient's survival and the proportion of NCA-containing cells was also observed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Audette M, Buchegger F, Schreyer M, Mach J-P (1987) Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of cross-reacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes. Mol Immunol 24: 1177–1186
Bosslet K, Lüben G, Schwarz A, Hundt E, Harthus HP, Seiler FR, Muhrer C, Klöppel G, Kayser K, Sedlacek HH (1985) Immunohistochemical localization and molecular characteristics of three monoclonal antibody-defined epitopes detectable on carcinoembryonic antigen (CEA). Int J Cancer 36: 75–84
Buchegger F, Schreyer M, Carrel S, Mach J-P (1984) Monoclonal antibodies identify a CEA cross-reacting antigen of 95 kD (NCA-95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kD. Int J Cancer 33: 643–649
Burtin P, Chavanel G, Hendrick JC, Frenoy N (1986) Antigenic variants of the nonspecific cross-reacting antigen (NCA). J Immunol 137: 839–845
Grunert F, AbuHarfeil N, Schwarz K, von Kleist S (1985) Two CEA and three NCA species, although distinguishable by monoclonal antibodies, have nearly identical peptide patterns. Int J Cancer 36: 357–362
Harłozińska A, Potomski J, Ławińska B, Noworolska A, Richter R (1982) High and low Fc IgG-receptor expression in human chronic granulocytic leukaemia cells. Br J Cancer 45: 194–200
Jothy S, Brazinsky SA, Chin-A-Loy M, Haggarty A, Krantz MJ, Cheung M, Fuks A (1986) Characterization of monoclonal antibodies to carcinoembryonic antigen with increased tumor specificity. Lab Invest 54: 108–117
Krop-Watorek A, Sedlaczek P, Lisowska E (1983) The subunit structure of non-specific cross-reacting antigen (NCA). Mol Immunol 20: 777–785
Noworolska A, Harłozińska A, Richter R, Brodzka W (1985) Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series. Br J Cancer 51: 371–377
Noworolska A, Harłozińska-Szmyrka A, Richter R (1986) Distribution of surface nonspecific cross-reacting antigen and influence of proteolytic enzymes on this antigen in myeloid cell series. Cancer Detect Prev 9: 365–371
Wahren B, Gahrton G, Rudén U, Hammerstrom S (1982) Clinical evaluation of NCA in patients with chronic myelocytic leukemia. Int J Cancer 29: 133–137
Author information
Authors and Affiliations
Additional information
Supported by Polish National Cancer Program No. 11.5, Grant No. 95.
Rights and permissions
About this article
Cite this article
Noworolska, A., Harłozińska, A., Buchegger, F. et al. Expression of nonspecific cross-reacting antigen species in myeloid leukemic patients and healthy subjects. Blut 58, 69–73 (1989). https://doi.org/10.1007/BF00320651
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00320651